Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis

BACKGROUND & AIMS: Adverse events (AEs) including reactivation of herpes zoster (HZ) and venous thromboembolism (VTE) have been reported from clinical trials of tofacitinib in ulcerative colitis (UC). We investigated the incidence rates of AEs in a real-world study of UC patients given tofacitin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Gastroenterol Hepatol
Main Authors: Deepak, Parakkal, Alayo, Quazim A., Khatiwada, Aava, Lin, Bixuan, Fenster, Marc, Dimopoulos, Christina, Bader, Geoffrey, Weisshof, Roni, Jacobs, Michael, Gutierrez, Alexandra, Ciorba, Matthew A., Christophi, George P., Patel, Anish, Hirten, Robert P, Colombel, Jean-Frederic, Rubin, David T., Ha, Christina, Beniwal-Patel, Poonam, Ungaro, Ryan C., Syal, Gaurav, Pekow, Joel, Cohen, Benjamin L., Yarur, Andres
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7779667/
https://ncbi.nlm.nih.gov/pubmed/32629130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2020.06.050
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados